|
🐜
|
Continuous growth of mean tumor diameter in a subset of grade II gliomas
10 auth.
E. Mandonnet,
J. Delattre,
M. Tanguy,
K. Swanson,
A. Carpentier,
H. Duffau,
...
P. Cornu,
R. van Effenterre,
E. Alvord,
L. Capelle
|
8 |
2003 |
8
🐜
|
|
🐜
|
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
11 auth.
J. Collet,
G. Montalescot,
B. Blanchet,
M. Tanguy,
J. Golmard,
R. Choussat,
...
F. Beygui,
L. Payot,
N. Vignolles,
J. Metzger,
D. Thomas
|
8 |
2004 |
8
🐜
|
|
🐜
|
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis
12 auth.
J. Collet,
Y. Allali,
C. Lesty,
M. Tanguy,
J. Silvain,
A. Ankri,
...
B. Blanchet,
R. Dumaine,
J. Gianetti,
L. Payot,
J. Weisel,
G. Montalescot
|
8 |
2006 |
8
🐜
|
|
🐜
|
Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity.
8 auth.
V. Foltz,
F. Gandjbakhch,
F. Etchepare,
C. Rosenberg,
M. Tanguy,
S. Rozenberg,
...
P. Bourgeois,
B. Fautrel
|
7 |
2012 |
7
🐜
|
|
🐜
|
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
27 auth.
A. Gonzalez-Aguilar,
A. Idbaih,
B. Boisselier,
Naïma Habbita,
M. Rossetto,
A. Laurenge,
A. Bruno,
A. Jouvet,
M. Polivka,
C. Adam,
D. Figarella-Branger,
C. Miquel,
A. Vital,
H. Ghesquières,
R. Gressin,
...
V. Delwail,
L. Taillandier,
O. Chinot,
P. Soubeyran,
E. Gyan,
S. Choquet,
C. Houillier,
C. Soussain,
M. Tanguy,
Y. Marie,
K. Mokhtari,
K. Hoang-Xuan
|
7 |
2012 |
7
🐜
|
|
🐜
|
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
30 auth.
N. Costedoat-Chalumeau,
L. Galicier,
O. Aumaître,
C. Francès,
V. le Guern,
F. Lioté,
A. Smail,
N. Limal,
L. Pérard,
H. Desmurs‐Clavel,
D. Boutin,
B. Asli,
J. Kahn,
J. Pourrat,
L. Sailler,
...
F. Ackermann,
T. Papo,
K. Sacré,
O. Fain,
J. Stirnemann,
P. Cacoub,
M. Jallouli,
G. Leroux,
J. Cohen‐Bittan,
M. Tanguy,
J. Hulot,
P. Lechat,
L. Musset,
Z. Amoura,
J. Piette
|
7 |
2012 |
7
🐜
|
|
🐜
|
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial.
17 auth.
J. Gállego Pérez-Larraya,
F. Ducray,
O. Chinot,
I. Catry-Thomas,
L. Taillandier,
J. Guillamo,
C. Campello,
A. Monjour,
S. Cartalat‐Carel,
M. Barrié,
...
A. Huchet,
P. Beauchesne,
M. Matta,
K. Mokhtari,
M. Tanguy,
J. Honnorat,
J. Delattre
|
7 |
2011 |
7
🐜
|
|
🐜
|
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.
40 auth.
C. Houillier,
L. Taillandier,
S. Dureau,
T. Lamy,
M. Laadhari,
O. Chinot,
C. Moluçon-Chabrot,
P. Soubeyran,
R. Gressin,
S. Choquet,
G. Damaj,
A. Thyss,
J. Abraham,
V. Delwail,
E. Gyan,
...
L. Sanhes,
J. Cornillon,
R. Garidi,
A. Delmer,
M. Tanguy,
A. Al Jijakli,
P. Morel,
P. Bourquard,
M. Moles,
A. Chauchet,
T. Gastinne,
J. Constans,
A. Langer,
Antoine Martin,
P. Moisson,
L. Lacomblez,
N. Martin-Duverneuil,
D. Delgadillo,
I. Turbiez,
L. Feuvret,
N. Cassoux,
V. Touitou,
D. Ricard,
K. Hoang-Xuan,
C. Soussain
|
7 |
2019 |
7
🐜
|
|
🐜
|
Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With Enoxaparin
10 auth.
G. Montalescot,
J. Collet,
M. Tanguy,
A. Ankri,
L. Payot,
R. Dumaine,
...
R. Choussat,
F. Beygui,
Vanessa Gallois,
Daniel Thomas
|
7 |
2004 |
7
🐜
|
|
🐜
|
Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.
23 auth.
A. Omuro,
O. Chinot,
L. Taillandier,
H. Ghesquières,
C. Soussain,
V. Delwail,
T. Lamy,
R. Gressin,
S. Choquet,
P. Soubeyran,
...
A. Huchet,
A. Benouaich‐Amiel,
S. Lebouvier-Sadot,
E. Gyan,
V. Touitou,
M. Barrié,
M. S. del Rio,
A. Gonzalez-Aguilar,
C. Houillier,
D. Delgadillo,
L. Lacomblez,
M. Tanguy,
K. Hoang-Xuan
|
7 |
2015 |
7
🐜
|
|
🐜
|
B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.
12 auth.
G. Jondeau,
Y. Neuder,
J. Eicher,
P. Jourdain,
É. Fauveau,
M. Galinier,
...
A. Jégou,
F. Bauer,
J. Trochu,
A. Bouzamondo,
M. Tanguy,
P. Lechat
|
7 |
2009 |
7
🐜
|
